Revenue: The sum of all revenue fields included for a company's operating activities.
Alaunos Therapeutics, Inc. (TCRT) had Revenue of $0.01M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$0.01M |
$-4.68M |
|
-- |
|
$0.01M |
|
$4.82M |
|
$-4.81M |
|
$0.13M |
|
$-4.68M |
|
$-4.68M |
|
$-4.68M |
|
$-4.68M |
|
$-4.68M |
|
$-4.68M |
|
$-4.81M |
|
$-4.81M |
|
1.60M |
|
1.60M |
|
$-2.92 |
|
$-2.92 |
|
| Balance Sheet Financials | |
$2.75M |
|
-- |
|
-- |
|
$2.75M |
|
$0.69M |
|
-- |
|
-- |
|
$0.69M |
|
$2.06M |
|
$2.06M |
|
$2.06M |
|
1.60M |
|
| Cash Flow Statement Financials | |
$-4.97M |
|
$0.00M |
|
$0.00M |
|
$6.06M |
|
$1.09M |
|
$-4.97M |
|
$0.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.98 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-48120.00% |
|
-48120.00% |
|
-48100.00% |
|
-46790.00% |
|
-46790.00% |
|
$-4.97M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
2.00 |
|
182.50 |
|
-226.80% |
|
-226.81% |
|
-169.84% |
|
-226.81% |
|
$1.29 |
|
$-3.10 |
|
$-3.10 |
|